Antares Pharma Provides Xyosted Regulatory Update

EWING, N.J., April 05, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) (the Company) today announced that the U.S. Food and Drug Administration (FDA or the Agency) acknowledged receipt of the Company ’s March 29, 2018 resubmission to...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news